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Background: Obstructive sleep apnea (OSA) and arterial hypertension (AH) are common and underrecognized
medical disorders. OSA is a potential risk factor for the development of AH and/or may act as a factor complicating
AH management. The symptoms of excessive daytime sleepiness (EDS) are considered essential for the initiation of
continuous positive airway pressure (CPAP) therapy, which is a first line treatment of OSA. The medical literature
and practice is controversial about the treatment of people with asymptomatic OSA. Thus, OSA patients without
EDS may be left at increased cardiovascular risk.
Case presentation: The report presents a case of 42 year old Asian woman with symptoms of heart failure and
angina like chest pain upon admission. She didn’t experience symptoms of EDS, and the Epworth Sleepiness Scale
was seven points. Snoring was reported on direct questioning. The patient had prior medical history of three
unsuccessful pregnancies complicated by gestational AH and preeclampsia with C-section during the last
pregnancy. The admission blood pressure (BP) was 200/120 mm Hg. The patient’s treatment regimen consisted of
five hypotensive medications including diuretic. However, a target BP wasn’t achieved in about one and half month.
The patient was offered to undergo a polysomnography (PSG) study, which she rejected. One month after
discharge the PSG study was done, and this showed an apnea-hypopnea index (AHI) of 46 events per hour. CPAP
therapy was initiated with a pressure of 11 H20 cm. After 2 months of compliant CPAP use, adherence to
pharmacologic regimen and lifestyle modifications the patient’s BP decreased to 134/82 mm Hg.
Conclusions: OSA and AH are common and often underdiagnosed medical disorders independently imposing
excessive cardiovascular risk on a diseased subject. When two conditions coexist the cardiovascular risk is likely
much greater. This case highlights a possible clinical phenotype of OSA without EDS and its association with
resistant AH. Most importantly a good hypotensive response to medical treatment in tandem with CPAP therapy
was achieved in this patient. Thus, it is reasonable to include OSA in the differential list of resistant AH, even if EDS
is not clinically obvious.
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Obstructive sleep apnea (OSA)-is the disorder character-
ized by complete or partial breathing disturbances during
sleep with a minimum prerequisite frequency of 5 events
per hour and lasting for at least 10 seconds [1]. The
prevalence of OSA varies in epidemiological surveys, and
this can be explained by different populations studied
and including excessive daytime sleepiness (EDS) as a
criterion for OSA diagnosis [2]. Thus, it is likely that the
real number of the affected population is much higher
than reported.
OSA is associated with increased cardiovascular risk
and OSA in particular may be an independent risk factor
for the development of arterial hypertension (AH) [3].
AH on the other hand, is a major cardiovascular risk fac-
tor and among the most prevalent chronic conditions
worldwide [4]. The association between AH and OSA
without symptoms of EDS is conflicting and there are
controversies regarding the place of continuous positive
airway pressure (CPAP) therapy in such situations. Thus,
non-sleepy OSA individuals may be dishonestly left with
increased cardiovascular risk.
Case presentation
A 42 year old female of Asian descent was admitted to the
ward with complaints of dyspnea and squeezing chest pain
without radiation during mild to moderate physical activ-
ity, pitting edema of the lower extremities, nocturia and
treatment resistant AH. For the last 6 months, the patient
experienced shortness of breath and lower extremities pit-
ting edema which had worsened with time. During this
period, the patient reported fatigue, which was related to
the aforementioned symptoms from the patient’s own
words. Upon questioning the patient reported loud snor-
ing during sleep, but denied sleepiness during the wake
time.
The patient is Gravida 3 Para 0. The first 2 pregnancies
were complicated with gestational hypertension (which
were resolved after pregnancies) with stillbirths and the
last one with preeclampsia and emergent C-section de-
livery of demised infant at 30 weeks term.
AH was diagnosed at 2006, during regular outpatient
visit with measured blood pressure (BP) 186/110 mm Hg
at that time. Since then, the patient noticed angina like
chest pain during regular physical activity. Family history
is remarkable for obesity and AH in both of her parents.
The patient’s prehospitalization regimen consisted of
100 mg of atenolol a day and 20 mg of enalapril a day,
which is not believed to be an optimal hypotensive com-
bination therapy [5]. The patient’s BP ranged from 160/
100 mm Hg to 240/130 mm Hg (which is the highest
retrospectively recorded BP in this patient). The patient
denied smoking, alcohol intake or use of any psychostimu-
lating (including caffeine containing products) remedies.The patient is obese for the last 15 years, but since
2009 she gained approximately 10 kilograms. The patient
ate fatty meals with average daily calorie intake of ap-
proximately 3000 Kcal/day and followed sedentary life-
style. The body weight was 103 kg, height was 156 cm,
abdominal circumference was 134 cm and body mass
index was 42.3 kg/m2 upon admission.
Cardiovascular examination: heart rate (HR) was 85 beats
per minute. The loud second heart sound was heard over
the right second intercostal space. No murmurs, rubs or
gallops upon auscultation were heard. Bilateral pitting
edema was present over the shins. Admission BP was 200/
120 mm Hg.
On the pulmonary exam, bilateral inspiratory rales were
present at the bases with no change on coughing. The re-
spiratory rate was 19 per minute. Digital pulse oximetry
revealed oxygen saturation of 95%.
Oral examination revealed redundant pharyngeal soft
tissue and Mallampati class 3 [6]. Neck circumference
was 43 cm the thyroid gland wasn’t palpable. No hair
loss, skin changes or alterations in bowel habits were
present. Neurological exam was intact. The Epworth sleepi-
ness score (ESS) was seven points [7].
Complete blood count, Creatinine, electrolytes, glom-
erular filtration rate, liver function tests (ALT, AST),
troponin level, fasting lipid panel, fasting glucose (on 2
separate occasions) and thyroid function tests were all
within normal limits.
Electrocardiography (ECG): inverted T waves in leads
V3-V6. Holter ECG monitoring: 1 paroxysm of atrial fibril-
lation with HR of 134 beats/minute lasting for 21 seconds.
Frequent episodes of T wave inversion without overt ST
segment abnormalities.
Echocardiography: left ventricular end diastolic dimen-
sion: 6.45 cm, left ventricular end systolic dimension:
5.01 cm, interventricular septum: 1.36 cm, posterior wall
of the left ventricle: 1.27 cm and ejection fraction of 43%.
Mild diffuse left ventricular hypokinesis was present. Other
parameters were within normal limits.
Carotid ultrasound: left common carotid intima media
thickness of 0.91 and right common carotid TIM of 0.92
without obvious plaques.
24 hour BP measurement: non dipping pattern, with
only 3% of nighttime decline of BP. Important to note
that nighttime BP is known to be a stronger predictor of
cardiovascular events than daytime BP [8].
Chest X-Ray: Pulmonary venous congestion and car-
diothoracic index of 49%.
The hospital stay was 20 days. The patient’s hypotensive
regimen is present in Table 1. On this regimen the patient’s
BP ranged from 150/90 to170/110 mm Hg. HR was 62–70
beats per minute. Besides the pharmacological interven-
tion, the patient was counseled on proper low fat/calorie
diet and other measures to improve her lifestyle.
Table 1 Hypotensive regimen at the hospital
Medication Dose
Bisoprolol 10 mg a day
Candesartan 32 mg a day
Indapamide SR 1.5 mg a day
Amlodipine 10 mg a day
Moxonidine 400 mcg a day
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this patient was obese and had high diastolic BP some
possible alternative etiologies were considered such as
obesity related AH, hypothyroidism, OSA etc.
Since OSA was in the differential list, this patient was
offered a PSG study, which she rejected at that time.
The patient was discharged with the BP of 160/106 mm
Hg and instructed to return for follow up visit in 2 weeks
as outpatient.
The patient arrived only 1 month after and assured
that she didn’t have any compliance related problems.
The BP was 158/110 mm Hg. Dyspnea became less se-
vere and the angina episodes less frequent.
The possibility of OSA was again discussed with the
patient and PSG study was offered, which was agreed at
that time. The recording of the patient’s PSG study is
present in Figure 1.
The 12 hour PSG revealed the apnea-hypopnea index
(AHI) of 46 events per hour, which is consistent with a
severe form of the disease [1]. On the next night, the
CPAP titration study with the pressure of 11 H20 cm
abolished the sleep disordered breathing events. The
patient was instructed on proper and compliant use of
CPAP machine. Follow up was scheduled in 2 months.
After 2 months, the patient’s CPAP using time was on
average 6 hours per night and 7 days a week. The BP onFigure 1 Patient’s PSG recording. Abbreviations: ECG-electrocardiog
EOG-electrooculography, SaO2-oxygen saturation.this visit was 140/92 mm Hg on prior pharmacological
regimen and CPAP therapy.
One month later, the patient’s BP became 134/82 mm Hg.
The patient’s treatment regimen wasn’t modified during this
time interval. Home sleep monitoring detected the AHI of
six events per hour.Discussion
Resistant AH is defined as inability to reach target BP
using at least 3 different hypotensive medications includ-
ing diuretic [9]. The differential list is broad and includes:
lack of treatment compliance, inadequate treatment regi-
men, hypervolemic states, identifiable causes of AH, obes-
ity and OSA [10].
It is well known that OSA is a potential risk factor for
AH development and/or a factor complicating its treat-
ment. Currently the symptoms of EDS are considered es-
sential for the initiation of CPAP therapy, while patients
with pathologic AHI and without EDS are generally not
treated. However, it is noteworthy to mention that OSA
with EDS has the strongest association with resistant AH
[11].
In their landmark study, Barbe and colleagues high-
lighted the beneficial effects of CPAP therapy in non-
sleepy OSA subjects who were compliant with CPAP
therapy. However in their study the effect on BP was
only evident after one year of regular CPAP therapy [12].
In this patient several issues should be considered.
First, this is only a case report with all potential limita-
tions. Second, the impact of obesity and insulin resist-
ance weren’t measured in the patient, but it is important
to mention that the patient didn’t lose weight within
the 3 months follow up. Third, the patient decreased her
sodium intake from eight grams to four grams a day andraphy, EEG-electroencephalography, EMG-electromyography,
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the BP decline may be solely explained by hypotensive
effect of BP lowering medications. Fifth, ESS is known to
have some limitations, since it is a subjective test for
EDS [13]. A recent study highlighted the fact that patients
with OSA and concomitant heart failure (HF) can present
without symptoms of EDS assessed with ESS [14]. How-
ever, others in a smaller number of recruited participants
have failed to show that patients with OSA and HF have
less EDS [15]. But, on the other hand, ESS may have lim-
ited sensitivity for detecting EDS in patients with OSA and
concomitant HF.
Nevertheless, this report highlights the possibility of a
distinct non sleepy clinical phenotype of OSA and its asso-
ciation with resistant AH. Thus, it is reasonable to include
OSA in the differential list of refractory to treatment AH,
even when the EDS is not clinically obvious.
Conclusion
OSA and AH are common and often underdiagnosed
medical disorders independently imposing excessive car-
diovascular risk on diseased subject. When two condi-
tions coexist the burden is likely much greater. This case
highlights a possible association between non-sleepy OSA
and AH, with good hypotensive response to BP lowering
medications in tandem with CPAP therapy. Thus, it is rea-
sonable to include OSA in the differential list of refractory
to treatment AH, even when the EDS is not clinically
obvious.
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